[ALNY] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -58.54%
YoY- 0.50%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 659,825 318,754 224,818 220,553 103,962 44,714 29,907 67.39%
PBT -11,167 -274,209 -274,673 -188,331 -177,903 -218,521 -163,481 -36.03%
Tax 5,722 1,815 2,729 1,228 1,326 960 79 104.03%
NP -16,889 -276,024 -277,402 -189,559 -179,229 -219,481 -163,560 -31.48%
Tax Rate - - - - - - - -
Total Cost 676,714 594,778 502,220 410,112 283,191 264,195 193,467 23.18%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -2.56 -86.59 -123.39 -85.95 -172.40 -490.86 -546.90 -59.06%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.13 -2.21 -2.29 -1.61 -1.56 -2.02 -1.63 -34.36%
EPS Diluted -0.13 -2.21 -2.29 -1.61 -1.56 -2.02 -1.63 -34.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.